1.Serum Alanine Aminotransferase Level as a Risk Factor for Coronary Heart Disease Prediction in Koreans: Analysis of the Korea National Health and Nutrition Examination Survey (V-1, 2010 and V-2, 2011)
Kiyoung KIM ; Dongsun KIM ; Kyu Nam KIM
Korean Journal of Family Medicine 2019;40(2):124-128
BACKGROUND: The blood level of alanine aminotransferase (ALT) is associated with increased coronary heart disease (CHD) risk. However, its use as an independent factor for CHD risk prediction remains unclear in Asian populations. The purpose of this study was to examine the association between serum ALT levels and CHD risk in Koreans. METHODS: This was a cross-sectional study using data from the Korea National Health and Nutrition Examination Survey (V-1, 2010 and V-2, 2011). The ALT levels of 3,215 individuals were analyzed. The Framingham Risk Score (FRS) modified by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) was used to compute the 10-year CHD risk prediction. RESULTS: Positive correlations were established between log-transformed ALT concentration and FRS (r=0.433, P<0.001). After adjusting for body mass index, low-density lipoprotein cholesterol, the amount of alcohol intake, and gamma-glutamyl transferase, the odds ratio (95% confidence interval) for intermediate or greater risk of 10- year CHD prediction (10-year risk ≥10%) for the lowest quartile of participants was 2.242 (1.405–3.577) for the second quartile, 2.879 (1.772–4.679) for the third quartile, and 3.041 (1.789–5.170) for the highest quartile. CONCLUSION: In Koreans, a higher serum ALT concentration was significantly correlated with 10-year CHD risk prediction according to NCEP ATP III guidelines.
Adenosine Triphosphate
;
Adult
;
Alanine Transaminase
;
Alanine
;
Asian Continental Ancestry Group
;
Body Mass Index
;
Cholesterol
;
Coronary Disease
;
Cross-Sectional Studies
;
Education
;
Humans
;
Korea
;
Lipoproteins
;
Nutrition Surveys
;
Odds Ratio
;
Risk Factors
;
Transferases
2.Surrogate Measures of Insulin Resistance in an Apparently Healthy Population: a Simpler and Easier, yet Reliable Index.
Journal of Korean Medical Science 2018;33(29):e195-
No abstract available.
Insulin Resistance*
;
Insulin*
3.The Necessity of the Simple Tests for Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus Patients without Neuropathic Symptoms in Clinical Practice.
Diabetes & Metabolism Journal 2018;42(5):442-446
Early recognition and appropriate management of diabetic peripheral polyneuropathy (DPNP) is important. We evaluated the necessity of simple, non-invasive tests for DPNP detection in clinical practice. We enrolled 136 randomly-chosen patients with type 2 diabetes mellitus and examined them with the 10-g Semmes-Weinstein monofilament examination, the 128-Hz tuning-fork, ankle-reflex, and pinprick tests; the Total Symptom Score and the 15-item self-administered questionnaire of the Michigan Neuropathy Screening Instrument. Among 136 patients, 48 had subjective neuropathic symptoms and 88 did not. The abnormal-response rates varied depending on the methods used according to the presence of subjective neuropathic symptoms (18.8% vs. 5.7%, P < 0.05; 58.3% vs. 28.4%, P < 0.005; 81.3% vs. 54.5%, P < 0.005; 12.5% vs. 5.7%, P=0.195; 41.7% vs. 2.3%, P < 0.001; and 77.1% vs. 9.1%, P < 0.001; respectively). The largest abnormal response was derived by combining all methods. Moreover, these tests should be implemented more extensively in diabetic patients without neuropathic symptoms to detect DPNP early.
Diabetes Mellitus
;
Diabetes Mellitus, Type 2*
;
Diabetic Neuropathies
;
Diagnosis
;
Humans
;
Mass Screening
;
Michigan
;
Neurologic Examination
;
Peripheral Nervous System Diseases*
;
Polyneuropathies
;
Surveys and Questionnaires
4.Response: The Necessity of the Simple Tests for Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus Patients without Neuropathic Symptoms in Clinical Practice (Diabetes Metab J 2018;42:442–6).
Diabetes & Metabolism Journal 2018;42(6):546-547
No abstract available.
Diabetes Mellitus, Type 2*
;
Humans
;
Peripheral Nervous System Diseases*
5.Withdrawal: Specific nephrotoxicity and cardiotoxicity of BT-CAL®, Sigma Anti-bonding Molecule Calcium Carbonate, in mice.
Ja Young JANG ; Jingmei CAI ; Jihyun KIM ; Jangbeen KYUNG ; Dajeong KIM ; Ehn Kyoung CHOI ; Youngeun KIM ; Kwang Sei KIM ; Dongsun PARK ; Hyun Gu KANG ; Yun Bae KIM
Laboratory Animal Research 2016;32(2):134-134
This article has been retracted.
6.Emphysematous Gastritis with Concomitant Portal Venous Air and Acute Necrotizing Esophagitis in Type 1 Diabetes with Diabetic Ketoacidosis: A Case Report and Literature Review of a Rare Complication in Diabetes.
Hyunwoo OH ; Hyoyoung LEE ; Ki Sul CHANG ; Jung Hwan PARK ; Sang Mo HONG ; Hang Lak LEE ; Chang Bum LEE ; Yongsoo PARK ; Dongsun KIM ; Woong Hwan CHOI ; Won Sang CHUNG ; You Hern AHN
Journal of Korean Diabetes 2016;17(2):139-145
Emphysematous gastritis is a rare disorder characterized by emphysematous change of the gastric wall due to infection with a gas-forming organism. Acute necrotizing esophagitis is a rare disorder with an unknown pathogenesis. Above two disorders rarely occur together, only three global cases have been reported to date. Such a case has never been reported in Korea, we report a novel case of severe emphysematous gastritis with concomitant portal venous air and acute necrotizing esophagitis in type 1 diabetes presenting with diabetic ketoacidosis. A 24-year-old man known to have type 1 diabetes and pulmonary tuberculosis was brought to the emergency room for epigastric pain with vomiting. His body mass index was 14.7, and the laboratory findings demonstrated leukocytosis and acidosis, as well as elevated serum glucose, ketone, and C-reactive protein levels. Enhanced computed tomography showed portal vein gas and edematous wall thickening without enhancement in the stomach wall, with air density along the stomach and esophageal wall. The patient required surgical intervention of total gastrectomy and cervical esophagostomy followed by esophagocolostomy and esophageal reconstruction. Early radiologic diagnosis and clinical suspicion of this disease and prompt intervention including antibiotics, decompression, and surgery are important for a good prognosis.
Acidosis
;
Anti-Bacterial Agents
;
Blood Glucose
;
Body Mass Index
;
C-Reactive Protein
;
Decompression
;
Diabetic Ketoacidosis*
;
Diagnosis
;
Emergency Service, Hospital
;
Esophagitis*
;
Esophagostomy
;
Gastrectomy
;
Gastritis*
;
Humans
;
Korea
;
Leukocytosis
;
Portal Vein
;
Prognosis
;
Stomach
;
Tuberculosis, Pulmonary
;
Vomiting
;
Young Adult
7.Erratum: Synergistic anti-inflammatory effects of Laminaria japonica fucoidan and Cistanche tubulosa extract.
Jangbeen KYUNG ; Dajeong KIM ; Dongsun PARK ; Yun Hui YANG ; Ehn Kyoung CHOI ; Sung Pyo LEE ; Tae Su KIM ; Yoon Bok LEE ; Yun Bae KIM
Laboratory Animal Research 2015;31(3):153-153
As the request of the authors, one paragraph has been changed.
8.A Dunnione Compound MB12662 Improves Cisplatin-Induced Tissue Injury and Emesis.
Dongsun PARK ; In Geun JO ; Ja Young JANG ; Tae Hwan KWAK ; Sang Ku YOO ; Jeong Hee JEON ; Ehn Kyoung CHOI ; Seong Soo JOO ; Okjin KIM ; Yun Bae KIM
Biomolecules & Therapeutics 2015;23(5):449-457
The present study was aimed to investigate the effects of MB12662, a synthetic dunnione compound, on cisplatin-induced vomiting reflexes and intestinal, renal, immune system, and hematopoietic toxicities in ferrets and mice, respectively. Male ICR mice were orally administered MB12662 (5, 10, 25 or 50 mg/kg) for 10 days, during which intraperitoneally challenged with cisplatin (3.5 mg/kg) from day 4 to 7, and sacrificed on day 10 for the pathological examination. Male ferrets were orally administered MB12662 (25, 50 or 100 mg/kg) for 7 days, subcutaneously challenged with cisplatin (5 mg/kg), and monitored for vomiting reflexes and survival of the animals. Four-day injection of cisplatin (3.5 mg/kg) to mice caused body weight loss and degeneration and atrophy of intestinal villi, reducing villi/crypt ratio to a half level of control animals. Cisplatin also induced renal and hepatic toxicities, and depletion of splenocytes and bone marrow progenitor cells. The systemic toxicities including decreased villi/crypt ratio, immune system atrophy, splenocyte depletion, and decreased cellularity in bone marrow were improved by MB12662. Cisplatin (5 mg/kg) induced retching and emetic responses of ferrets, which were remarkably attenuated by MB12662 in a dose-dependent manner. All the ferrets pretreated with MB12662 survived the challenge of cisplatin, in comparison with 40% mortality in vehicle-treated animals, and blood parameters of nephrotoxicity and hepatotoxicity were markedly recovered. It is expected that MB12662 could be a candidate for the body protection against burden, including emesis, of chemotherapeutic agents.
Animals
;
Atrophy
;
Body Weight
;
Bone Marrow
;
Cisplatin
;
Ferrets
;
Humans
;
Immune System
;
Male
;
Mice
;
Mice, Inbred ICR
;
Mortality
;
Reflex
;
Stem Cells
;
Vomiting*
9.Effectiveness of the combinational treatment of Laminaria japonica and Cistanche tubulosa extracts in hair growth.
Kyungha SHIN ; Tae Su KIM ; Jangbeen KYUNG ; Dajeong KIM ; Dongsun PARK ; Ehn Kyoung CHOI ; Sung Pyo LEE ; Woong Suk YANG ; Myung Hwa KANG ; Yun Bae KIM
Laboratory Animal Research 2015;31(1):24-32
Since scalp hair loss has increased recently even in young people, seriously affecting individual's quality of life, the hair growth-stimulating effects of Laminaria japonica extract (LJE) and Cistanche tubulosa extract (CTE) were investigated. After confirming anagen phase of follicles under shaving, male C57BL/6 mice were dermally applied with 3% Minoxidil or orally administered with the combinations of LJE and CTE for 21 days. Minoxidil promoted the hair regrowth and increased gamma-glutamyl transpeptidase (gamma-GTP) and alkaline phosphatase (ALP) activities. In addition, Minoxidil up-regulated epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) levels. Co-administration of LJE and CTE at 54 mg/kg LJE plus 162 mg/kg CTE exerted synergistic promoting effects on the hair regrowth, comparable to 3% Minoxidil. LJE preferentially enhanced ALP activity, while CTE increased both gamma-GTP and ALP activities as well as EGF and VEGF expressions. In vivo air pouch inflammation model, carrageenan-induced vascular exudation and increased nitric oxide and prostaglandin E2 concentrations in the exudates were synergistically suppressed by co-administration of LJE and CTE. In addition, inflammatory cell infiltration was substantially inhibited by the combinational treatment. The results suggest that combinational oral treatment with LJE and CTE in appropriate doses and ratios prevent hair loss and improve alopecia, which might be in part mediated by their anti-inflammatory activities.
Alkaline Phosphatase
;
Alopecia
;
Animals
;
Cistanche*
;
Dinoprostone
;
Epidermal Growth Factor
;
Exudates and Transudates
;
gamma-Glutamyltransferase
;
Hair*
;
Humans
;
Inflammation
;
Laminaria*
;
Male
;
Mice
;
Minoxidil
;
Nitric Oxide
;
Quality of Life
;
Scalp
;
Vascular Endothelial Growth Factor A
10.Neuroprotective Effects of a Butanol Fraction of Rosa hybrida Petals in a Middle Cerebral Artery Occlusion Model.
Goeun YANG ; Dongsun PARK ; Sun Hee LEE ; Dae Kwon BAE ; Yun Hui YANG ; Jangbeen KYUNG ; Dajeong KIM ; Ehn Kyoung CHOI ; Jin Tae HONG ; Heon Sang JEONG ; Hee Jung KIM ; Su Kil JANG ; Seong Soo JOO ; Yun Bae KIM
Biomolecules & Therapeutics 2013;21(6):454-461
The neuroprotective effects of a butanol fraction of white rose petal extract (WRPE-BF) were investigated in a middle cerebral artery occlusion (MCAO) model. Seven week-old male rats were orally administered WRPE-BF for 2 weeks and subjected to MCAO for 2 h, followed by reperfusion. Twenty-four h later, MCAO-induced behavioral dysfunctions were markedly improved in a dose-dependent manner by pretreatment with WRPE-BF. Moreover, higher dose of WRPE-BF not only decreased infarction area but also effectively reduced astrogliosis. The expression of inducible nitric oxide synthase, cyclooxygenase-2, and glial fibrillary acidic protein in MCAO model were markedly inhibited by WRPE-BF treatment. Notably, WRPE-BF decreased nitric oxide and malondialdehyde levels in the striatum and subventricular zone of stroke-challenged brains. These data suggested that WRPE-BF may exert its neuroprotective effects via anti-oxidative and anti-inflammatory activities against ischemia-reperfusion brain injury and could be a good candidate as a therapeutic target for ischemic stroke.
Animals
;
Brain
;
Brain Injuries
;
Cyclooxygenase 2
;
Glial Fibrillary Acidic Protein
;
Humans
;
Infarction
;
Infarction, Middle Cerebral Artery*
;
Male
;
Malondialdehyde
;
Middle Cerebral Artery*
;
Neuroprotective Agents*
;
Nitric Oxide
;
Nitric Oxide Synthase Type II
;
Rats
;
Reperfusion
;
Rosa*
;
Stroke

Result Analysis
Print
Save
E-mail